Praxis Precision Medicines, Inc. — Director's Dealing 2021

Feb 16, 2021

SEC Form 4/A — Form 4/A

Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2020-10-20

Reporting Person: Vitorovic Stefan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-20	Common Stock	C	2689329	—	Acquired	2689329	Indirect
2020-10-20	Common Stock	P	250000	$19	Acquired	2939329	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-20	Series B Preferred Stock	$	C	4150000	Disposed		Common Stock (1939295.0)	Indirect
2020-10-20	Series B-1 Preferred Stock	$	C	551794	Disposed		Common Stock (257853.0)	Indirect
2020-10-20	Series C Preferred Stock	$	C	171410	Disposed		Common Stock (80100.0)	Indirect
2020-10-20	Series C-1 Preferred Stock	$	C	881835	Disposed		Common Stock (412081.0)	Indirect

Footnotes

F1: All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date.

F2: These shares are held directly by Vida Ventures, LLC, a United States limited liability company. The Reporting Person is a managing director of Vida Ventures, LLC and is also a member of the board of directors of the Issuer. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein, if any.